The Department of Molecular Medicine in the Institute of Biotechnology was established to administer a program to train graduate students at the interface of basic and clinical sciences with an emphasis on biomedical research focused on discovering the molecular mechanisms underlying human disease and to serve as a platform for the development of novel treatment or prevention approaches. The program has awarded over 80 doctoral degrees and graduates are placed in top-tier research universities and pharmaceutical companies across the United States and Europe. Molecular Medicine offers a research-oriented, interdisciplinary program of study in the areas of cancer and aging and their prevention. Specific areas of study include: cell and hormone signaling, gene expression, epigenetics, cell cycle and checkpoint controls, DNA damage repair and associated stress responses, and regulated protein turnover. Research includes a systems approach to molecular medicine that offers students an integrated training program spanning molecular and cellular biology, quantitative biology, computational biology, and genomics.
To learn more about the Department of Molecular Medicine, visit our site at http://molecularmedicine.uthscsa.edu/index.aspx